CXCR4 and cancer: By determining the cancer cell fraction (CCF) of CXCR4 mutations in WM the mutation S338X was identified as mostly sub-clonal with variable clonal distribution, which points to the mutation as a late oncogenic event acquired after MYD88 mutation.